28
Oct
2025

Medpharm Ltd.

Exhibitor at CPHI Frankfurt 2025 stand 6.0F83, Contract Manufacturing and Services
About Us

MedPharm is a CDMO specializing in topical and transepithelial formulation development, in vitro testing, and manufacturing services. Known as the global leader in dermal and transdermal product development, MedPharm also offers innovative solutions for respiratory, ophthalmic, otic, ungual, and other topical preparations.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • GB
  • 2018
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Contract Service
Primary activities
Contract Manufacturer
Contract Research Organisation
View company profile
Contact info
  • +44 14 8345 75 80
  • Website
  • Unit 1 Chancellor Court, 50 Occam Road, Surrey Research Park, GU2 7YN, Guildford, Surrey, United Kingdom
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 6.0F83, Contract Manufacturing and Services

Products Featured at CPHI Frankfurt 2025

  • MedSpray technology

    Product MedSpray technology

    MedSpray is a patented aerosol-based system developed by MedPharm for a range of applications. Known as a “patch-in-a-can”, MedSpray delivers the selected API onto the skin or other tissue surface. It is thermodynamically-optimized to maximize permeation and penetration of the API through the tissue, and u...
  • Manufacturing & Commercialization

    Product Manufacturing & Commercialization

    As a full-service CDMO, MedPharm provides comprehensive compounding, filling, packaging, serialization, and warehousing services for the commercial production of topical, transdermal, and transepithelial semisolid and liquid drug products. We also have dedicated suites designed specifically for the manufac...
  • Disease Activity Models/Tissue Culture

    Product Disease Activity Models/Tissue Culture

    MedPharm has developed proprietary models relevant for major disease areas such as psoriasis, atopic dermatitis, onychomycosis and continue to develop new ones through our dedicated innovation group. These sophisticated ex vivo experiments provide additional confidence to clients and their in...
  • Formulation Development

    Product Formulation Development

    MedPharm has more than 20 years’ experience developing topical and transdermal formulations. We can begin as early as API screening and support pre-formulation activities, lead formulation selection, formulation optimization and reverse engineering. We have had a role in taking over 55 products to mark...
  • Drug Release Studies/In Vitro Release Testing (IVRT)

    Product Drug Release Studies/In Vitro Release Testing (IVRT)

    MedPharm leverages its 20 years of experience to help develop and validate IVRT methods for its clients. We successfully perform IVRT based on FDA and EMA guidelines and continue to influence how these methods are utilized in regulatory submissions.

    IVRT is the established method recogniz...
  • In Vitro Permeation Testing (IVPT)

    Product In Vitro Permeation Testing (IVPT)

    MedPharm offers its customers options for IVPT, including our unique MedFlux-HT® automated flow-through system or classic static Franz cells.

    IVPT is used to measure the permeation and penetration of a drug through tissue and is an essential tool for optimizing topical and transdermal fo...